A non-pivotal Phase 1 bridging study of CHS-0214.
Phase of Trial: Phase I
Latest Information Update: 20 Mar 2017
Price : $35 *
At a glance
- Drugs Etanercept (Primary)
- Indications Plaque psoriasis; Rheumatoid arthritis
- Focus Pharmacokinetics
- 20 Mar 2017 New trial record
- 13 Mar 2017 According to a Coherus Biosciences media release, this study provided additional relative bioavailability data for CHS-0214.